Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
88 hedge funds and large institutions have $145M invested in Surgalign Holdings, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 13 closing their positions.
85% more capital invested
Capital invested by funds: $78.5M → $145M (+$66.7M)
55% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 20
38% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 13
6% more funds holding
Funds holding: 83 → 88 (+5)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
66% less call options, than puts
Call options by funds: $30K | Put options by funds: $87K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KAM
Krensavage Asset Management
New York
|
+$4.53M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$3.3M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.38M |
| 4 |
Millennium Management
New York
|
+$1.24M |
| 5 |
CLG
Cooperman Leon G
|
+$1.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KFO
Kopp Family Office
Bloomington,
Minnesota
|
-$6.17M |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$3.07M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$1.13M |
| 4 |
Renaissance Technologies
New York
|
-$628K |
| 5 |
JP Morgan Chase
New York
|
-$390K |
SRGA Hedge Fund Activity: Q2 2020 in Review
88 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q2 2020, worth a combined $145M — up 85% from $78.5M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new SRGA positions and 13 closed out — a net gain of 5 holders — while 31 added to existing stakes and 20 trimmed.
The largest buyer was Krensavage Asset Management, adding an estimated $4.53M. The largest seller was Kopp Family Office, exiting entirely with an estimated $6.17M sold.
- 88 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q2 2020, up from 83 in Q1 2020.
- Funds reported $145M of Surgalign Holdings, Inc. Common Stock stock for Q2 2020, up 85% quarter-over-quarter.
- 18 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q2 2020 and 13 closed out, a net change of +5 holders.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q2 2020 was Krensavage Asset Management, an estimated $4.53M added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q2 2020 was Kopp Family Office, an estimated $6.17M sold.
Based on aggregated 13F filings for Q2 2020.